Janney Montgomery Scott
TARS icon

Janney Montgomery Scott’s Tarsus Pharmaceuticals TARS Stock Holding History

Janney Montgomery Scott’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Buy
10,788
+253
+2% +$16.2K ﹤0.01% 2182
2026
Q1 		$739K Sell
10,535
-2,350
-18% -$164K ﹤0.01% 1818
2025
Q4 		$1.05M Sell
12,885
-1,220
-9% -$91.1K ﹤0.01% 1694
2025
Q3 		$838K Sell
14,105
-1,950
-12% -$96K ﹤0.01% 1816
2025
Q2 		$650K Hold
16,055
– – ﹤0.01% 1850
2025
Q1 		$825K Sell
16,055
-2,795
-15% -$138K ﹤0.01% 1666
2024
Q4 		$1.04M Sell
18,850
-2,218
-11% -$101K ﹤0.01% 1512
2024
Q3 		$693K Sell
21,068
-2,000
-9% -$56.2K ﹤0.01% 1745
2024
Q2 		$627K Buy
23,068
+2,167
+10% +$72.9K ﹤0.01% 1719
2024
Q1 		$760K Sell
20,901
-3,326
-14% -$97.8K ﹤0.01% 1688
2023
Q4 		$491K Buy
24,227
+2,500
+12% +$41.7K ﹤0.01% 1913
2023
Q3 		$386K Hold
21,727
– – ﹤0.01% 1968
2023
Q2 		$393K Buy
+21,727
New +$345K ﹤0.01% 2045
2023
Q1 		– Sell
-11,640
Closed -$171K – 2686
2022
Q4 		$171K Buy
+11,640
New +$193K ﹤0.01% 2407

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Janney Montgomery Scott's TARS Position: Q2 2026 in Review

Janney Montgomery Scott increased its Tarsus Pharmaceuticals (TARS) stake by 2.4% in Q2 2026, buying an estimated $16.2K and bringing the position to 10,788 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Janney Montgomery Scott first reported a position in TARS in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.05M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Janney Montgomery Scott held 10,788 shares of Tarsus Pharmaceuticals worth $679K as of Q2 2026.
  • Janney Montgomery Scott bought 253 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $16.2K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2182 holding.
  • Janney Montgomery Scott first reported a position in Tarsus Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Janney Montgomery Scott's Tarsus Pharmaceuticals position peaked at $1.05M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.